Arabic Arabic English English French French German German
dark

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Curebase today announced that InBios successfully utilized Curebase’s virtual site solution to power clinical studies for its SCoV-2 Ag Detect™ Rapid Test, which was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on May 6, 2021. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

COVID Vaccine’s 2nd Dose Boosts Body Immunity, MOH Says

Next Post

Avacta’s Diagnostic Division Achieves ISO 13485 Certification

Related Posts
Total
0
Share